News

Filter

Current filters:

CervarixPricing

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers

21-03-2012

In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

UK government to switch from Cervarix to Gardasil for HPV vaccination

25-11-2011

As of next September, a different vaccine will be used in the HPV vaccination program to protect girls…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingSanofiSanofi Pasteur MSDVaccinesWomen's Health

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix

29-09-2011

An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

GlaxoSmithKline to challenge Merck & Co in cervical cancer vaccine price war

20-10-2009

UK drug giant GlaxoSmithKline, which has finally received US Food and Drug Administration for its cervical…

CervarixGardasilGeneralGlaxoSmithKlineGSKHuman Papillomavirus Bivalent VaccineMerck KGaANorth AmericaOncologyPharmaceuticalPricingVaccines

Back to top